IPQ Inside the global regulatory dialogue

New and Generic Drug User Fees, 21st Century Cures Act, Fuel FDA Regulatory Process and Culture Changes for Combination Products

Jun 19th, 2017

Please Log in to print the full article

While PDUFA V mentioned the word “combination” only in terms of related products or submissions, the PDUFA VI commitment letter section on “enhancing regulatory science and expediting drug development” specifically calls out combination products as...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications